tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AstraZeneca Imfinzi combination approved for gastroesophageal junction cancers
The FlyAstraZeneca Imfinzi combination approved for gastroesophageal junction cancers
3d ago
AZN
AstraZeneca’s Imfinzi Gains US Approval for Gastric Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s Imfinzi Gains US Approval for Gastric Cancer Treatment
3d ago
FDA approves AstraZeneca’s Imfinzi as perioperative immunotherapy for GEJ cancer
PremiumThe Fly
FDA approves AstraZeneca’s Imfinzi as perioperative immunotherapy for GEJ cancer
4d ago
AZN
AstraZeneca: Strong Growth Potential with Robust Pipeline and Attractive Valuation
PremiumRatings
AstraZeneca: Strong Growth Potential with Robust Pipeline and Attractive Valuation
4d ago
AZN
AstraZeneca’s $2 Billion Maryland Expansion to Boost US Medicine Supply Chain
PremiumCompany Announcements
AstraZeneca’s $2 Billion Maryland Expansion to Boost US Medicine Supply Chain
5d ago
Harbour BioMed advances collaboration with AstraZeneca
PremiumThe FlyHarbour BioMed advances collaboration with AstraZeneca
5d ago
AZN
AstraZeneca plans $2B manufacturing investment in Maryland
Premium
The Fly
AstraZeneca plans $2B manufacturing investment in Maryland
8d ago
AZN
RFK told CDC to change website language on autism and vaccines, NYT reports
Premium
The Fly
RFK told CDC to change website language on autism and vaccines, NYT reports
8d ago
AZN
GSK
AstraZeneca’s Koselugo Gains FDA Approval for Adult NF1 Treatment
PremiumCompany Announcements
AstraZeneca’s Koselugo Gains FDA Approval for Adult NF1 Treatment
9d ago
AstraZeneca treatment of multiple myeloma granted orphan designation
PremiumThe Fly
AstraZeneca treatment of multiple myeloma granted orphan designation
10d ago
AZN
FDA approves AstraZeneca’s Koselugo for adults with NF1
PremiumThe Fly
FDA approves AstraZeneca’s Koselugo for adults with NF1
10d ago
AZN
AstraZeneca approves AstraZeneca’s Koselugo for adults with NF1
PremiumThe Fly
AstraZeneca approves AstraZeneca’s Koselugo for adults with NF1
10d ago
AZN
Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3
PremiumThe FlyGenprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3
10d ago
AZN
GNPX
Capital Group Increases Stake in AstraZeneca
Premium
Company Announcements
Capital Group Increases Stake in AstraZeneca
12d ago
AstraZeneca CFO Sells 15,000 American Depositary Shares
Premium
Company Announcements
AstraZeneca CFO Sells 15,000 American Depositary Shares
15d ago
FDA appoints Richard Pazdur as Director of CDER
PremiumThe Fly
FDA appoints Richard Pazdur as Director of CDER
18d ago
AZN
BMY
AstraZeneca CEO Gifts Shares to Family Members
PremiumCompany Announcements
AstraZeneca CEO Gifts Shares to Family Members
19d ago
AstraZeneca treatment of acute lymphocytic leukemia granted orphan status
PremiumThe Fly
AstraZeneca treatment of acute lymphocytic leukemia granted orphan status
19d ago
AZN
AstraZeneca announces baxdrostat met primary endpoint in Bax24 Phase III trial
PremiumThe Fly
AstraZeneca announces baxdrostat met primary endpoint in Bax24 Phase III trial
19d ago
AZN
Midday Fly By: Musk pay plan approved, ‘GTA VI’ delayed
PremiumThe FlyMidday Fly By: Musk pay plan approved, ‘GTA VI’ delayed
22d ago
BL
BX
AstraZeneca CEO warns U.K. faces generics-only future, Guardian reports
Premium
The Fly
AstraZeneca CEO warns U.K. faces generics-only future, Guardian reports
22d ago
AZN
AstraZeneca reports statistical significance in NATRON trial
Premium
The Fly
AstraZeneca reports statistical significance in NATRON trial
22d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >